Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT
XMYY-2025KY280
Unknown other active
Quick answer
Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT for DLL3-expressing Tumors is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- DLL3-expressing Tumors
- Phase
- Unknown
- Modality
- other
- Status
- active